Delivery Order SPE2DB25D3404-SPE2DB25FUNFP

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $5,372.85. The contract has a firm fixed price pricing type and a period of performance through March 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a $3,557.04 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $14,793.61 and is a firm fixed-price delivery order, with an ultimate completion date of April 18, 2025. The contract is not set aside and was openly competed. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $46,097.69 and a period of performance through March 31, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,070.72 firm fixed-price contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of February 24, 2025. Amerisourcebergen is the prime contractor, and the contract is not designated as a set-aside. The award is associated with a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of MULTAQ 400 MG TABLET 60S, with a ceiling value of $2,602.26. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 8, 2022. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $10,439.41. The contract is a Firm Fixed Price delivery order, with a period of performance through March 17, 2025. The contract was not set aside for any specific business type. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,847.70, is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 14, 2025. This contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,877.07, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024 and is a firm-fixed-price contract. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a cardiovascular medication, with a ceiling value of $2,671.19 and a completion date of September 18, 2023. The contract is a firm fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUNFP
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $3,663.84 and a performance period ending on May 2, 2025.

The contract is not set-aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any subcontractors. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to various government agencies, including the Defense Health Agency and U.S. Coast Guard, through December 2026.

Generated 7/31/25, 10:31 AM